KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $11.0 billion.

  • Pfizer's Long-Term Deferred Tax rose 3968.9% to $11.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 billion, marking a year-over-year increase of 3968.9%. This contributed to the annual value of $8.7 billion for FY2024, which is 4992.77% down from last year.
  • Per Pfizer's latest filing, its Long-Term Deferred Tax stood at $11.0 billion for Q3 2025, which was up 3968.9% from $10.3 billion recorded in Q2 2025.
  • Pfizer's Long-Term Deferred Tax's 5-year high stood at $17.3 billion during Q4 2023, with a 5-year trough of $2.5 billion in Q2 2021.
  • For the 5-year period, Pfizer's Long-Term Deferred Tax averaged around $8.0 billion, with its median value being $7.9 billion (2024).
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first surged by 15991.09% in 2022, then plummeted by 4992.77% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Long-Term Deferred Tax stood at $9.0 billion in 2021, then soared by 47.67% to $13.3 billion in 2022, then surged by 30.41% to $17.3 billion in 2023, then tumbled by 49.93% to $8.7 billion in 2024, then rose by 27.55% to $11.0 billion in 2025.
  • Its Long-Term Deferred Tax was $11.0 billion in Q3 2025, compared to $10.3 billion in Q2 2025 and $9.5 billion in Q1 2025.